No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer-Reference-Cited by-同舟云学术

No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer

Published:2009-11-29 Issue:2 Volume:37 Page:276-283
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Verburg Frederik Anton,Stokkel Marcel P. M.,Düren Christian,Verkooijen Robbert B. T.,Mäder Uwe,van Isselt Johannes W.,Marlowe Robert J.,Smit Johannes W.,Reiners Christoph,Luster Markus

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-009-1315-6.pdf

Reference25 articles.

1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109–42.

2. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787–803.

3. Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jarzab B, et al. Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 2004;150:105–12.

4. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003;88:1433–41.

5. Sobin LH, Wittekind C, editors. TNM classification of malignant tumours. 5th ed. Berlin: Springer; 1997.

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part II. Follow-up Surveillance after Initial Treatment 2024;International Journal of Thyroidology;2024-05-30

2. CACA guidelines for holistic integrative management of thyroid cancer;Holistic Integrative Oncology;2022-11-08

3. Long‐term predictive value of highly sensitive thyroglobulin measurement;Clinical Endocrinology;2022-11

4. Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns;Journal of Nuclear Medicine;2021-12

5. Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9–12 months after treatment;BJS Open;2021-11-01